Placebo-controlled study of mometasone furoate nasal spray (MFNS) 200 mcg QD in the treatment of seasonal allergic rhinitis

Trial Profile

Placebo-controlled study of mometasone furoate nasal spray (MFNS) 200 mcg QD in the treatment of seasonal allergic rhinitis

Completed
Phase of Trial: Phase III

Latest Information Update: 21 May 2014

At a glance

  • Drugs Mometasone (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 04 Mar 2010 Results published in the Journal of Allergy and Clinical Immunology.
    • 08 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top